Dn B Asset Management As 4 D Molecular Therapeutics, Inc. Transaction History
Dn B Asset Management As
- $21.2 Billion
- Q1 2025
A detailed history of Dn B Asset Management As transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Dn B Asset Management As holds 27,856 shares of FDMT stock, worth $100,838. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,856
Previous 16,298
70.92%
Holding current value
$100,838
Previous $90,000
1.11%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding FDMT
# of Institutions
128Shares Held
43.5MCall Options Held
25.8KPut Options Held
33.4K-
Black Rock Inc. New York, NY4.9MShares$17.7 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.56MShares$16.5 Million0.31% of portfolio
-
Bvf Inc San Francisco, CA4.56MShares$16.5 Million0.65% of portfolio
-
Goldman Sachs Group Inc New York, NY4.17MShares$15.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.76MShares$9.98 Million0.0% of portfolio
About 4D Molecular Therapeutics, Inc.
- Ticker FDMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,382,400
- Market Cap $117M
- Description
- 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...